Publication Cover
Human Fertility
an international, multidisciplinary journal dedicated to furthering research and promoting good practice
Volume 26, 2023 - Issue 6
62
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Association of menstrual blood volume and reproductive outcomes in patients with caesarean scar pregnancy managed using uterine artery embolization and curettage

, , , , , , , & show all
Pages 1491-1496 | Received 02 Aug 2022, Accepted 11 Apr 2023, Published online: 08 May 2023
 

Abstract

This study aimed to assess the association of menstrual blood volumes (MBV) and reproductive outcomes in patients after uterine artery embolization (UAE) combined with curettage for caesarean scar pregnancy (CSP). This retrospective observational study enrolled women who underwent UAE plus curettage for CSP at the Interventional Department of Henan Provincial People’s Hospital between December 2012 and December 2017. The primary outcome was pregnancy rate and the secondary outcomes were live birth rate (LBR) and interpregnancy interval. This study finally included 37 women (16 women with normal MBV and 21 women with decreased MBV) with pregnancy intention after UAE plus curettage for CSP. The pregnancy rate in women with normal MBV was higher than those with decreased MBV (81.3% vs. 47.6%; P = 0.048). There were no differences between the two groups regarding the interpregnancy interval (18.4 ± 8.7 vs. 22.2 ± 10.0 months, P = 0.233), and LBR (63% vs. 38%, P = 0.191). In conclusion, Women with normal MBV after UAE combined with curettage for CSP management might have a higher pregnancy rate compared with patients with decreased MBV, but there were no differences in LBR between the two groups.

Acknowledgements

Thanks to Jingge Zhao from the Clinical Research Center of Henan Provincial People’s Hospital for statistical analysis of the data in this study.

Ethics approval and consent to participate

This study was approved by the Ethics Committee of Henan Provincial People’s Hospital. All patients provided written informed consent. All methods are carried out in accordance with relevant guidelines.

Author contributions

Conception and design: CGS, LRQ; Administrative support: LJW; Provision of study materials or patients: LJ; Collection and assembly of data: LYY, LLP; Data analysis and interpretation: ZXY, LH, CHC; Manuscript writing: All authors; Final approval of manuscript: All authors.

Disclosure statement

The authors report there are no competing interests to declare

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Additional information

Funding

This study was supported by Beijing Medical Award Foundation (No. YXJL-2020-0972-0433). The funder have no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.